Skip to main content
Erschienen in: European Journal of Pediatrics 8/2005

01.08.2005 | Short Report

Impact of increased D-dimer concentrations in Kawasaki disease

verfasst von: Toshihiko Imamura, Takao Yoshihara, Kentaro Yokoi, Noriko Nakai, Hiroyuki Ishida, Yasuo Kasubuchi

Erschienen in: European Journal of Pediatrics | Ausgabe 8/2005

Einloggen, um Zugang zu erhalten

Excerpt

Increased D-dimer concentrations are a useful clinical marker to diagnose Kawasaki disease (KD). KD is associated with widespread vascular endothelial damage [2]. Thus, markers related to endothelial damage might be useful for the early and accurate diagnosis of KD [4,6]. Elevation of D-dimer was reported to be associated with some cases of systemic vasculitis [1,3] and was also previously reported to be increased in the acute phase of KD [5]; however, it has not yet been evaluated extensively. We therefore evaluated haemostatic markers in 11 KD patients diagnosed consecutively in our institute from September 2003 to June 2004. A total of 12 febrile patients referred to our hospital from January 2004 to June 2004 were included as controls (Table 1).
Table 1
Patients’ characteristics and laboratory findings. Data are given as median and range. The Mann-Whitney U test was used for between-group comparisons. A level of P <0.05 was accepted as significant
KDa
Controlb
P
N
11
12
Male/female
7/4
8/4
0.88
Age (years)
3.0 (0.7–6)
4.0 (1.0–6)
0.21
WBC (/μl)
13,900 (4,500–23,300)
11,550 (3,200–24,000)
0.32
Platelets (×104/μl)
34.3 (20.9–51.7)
29.45 (25.6–68.1)
0.52
CRP (mg/dl)
8.20 (0.8–16.5)
3.55 (0.6–21.5)
0.23
Fibrinogen (mg/dl)
673 (348–1055)
496 (367–692)
0.09
D-dimer (μg/ml)
1.87 (0.93–5.24)
0.75 (0.31–5.69) c
0.001
aA diagnosis of KD required at least five of six major clinical symptoms or at least four clinical symptoms and coronary lesions detected by echocardiogram examinations. All patients received intravenous immunoglobulin as initial therapy as soon as the diagnosis was established. Combined medications included acetylsalicylic acid during the febrile period, which was replaced with flurbioprofen in patients with liver dysfunction. Steroid therapy was not performed before and during admission. None of the KD patients in this study developed coronary aneurysm
bPatients older than 6 years of age, presenting with disseminated intravascular coagulopathy and a normal CRP value (normal <0.3 mg/dl) were excluded. Control patients included a variety of diseases as follows: three bacterial cervical lymphadenitis, two bronchitis, two tonsillitis, one pseudocroup, one Gianotti syndrome, one erythema multiforme major, and one myxoma
cOnly one patient with erythema multiforme major showed abnormal D-dimer concentrations (5.69 μg/ml)
Literatur
1.
Zurück zum Zitat Brendel-Müller K, Hahn A, Schneppenheim R, Santer R (2001) Laboratory signs of activated coagulation are common in Henoch-Schonlein purpura. Pediatr Nephrol 16: 1084–1088CrossRefPubMed Brendel-Müller K, Hahn A, Schneppenheim R, Santer R (2001) Laboratory signs of activated coagulation are common in Henoch-Schonlein purpura. Pediatr Nephrol 16: 1084–1088CrossRefPubMed
2.
Zurück zum Zitat Centers for Disease Control (1980) Kawasaki disease, New York. MMWR Morb Mortal Wkly Rep 29: 61 Centers for Disease Control (1980) Kawasaki disease, New York. MMWR Morb Mortal Wkly Rep 29: 61
3.
Zurück zum Zitat Hergesell O, Andrassy K, Nawroth P (1996) Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost 75: 892–898PubMed Hergesell O, Andrassy K, Nawroth P (1996) Elevated levels of markers of endothelial cell damage and markers of activated coagulation in patients with systemic necrotizing vasculitis. Thromb Haemost 75: 892–898PubMed
4.
Zurück zum Zitat Morise T, Takeuchi Y, Takeda R, Karayalcin U, Yachie A, Miyawaki T (1993) Increased plasma endothelin levels in Kawasaki disease: a possible marker for Kawasaki disease. Angiology 44: 719–723 Morise T, Takeuchi Y, Takeda R, Karayalcin U, Yachie A, Miyawaki T (1993) Increased plasma endothelin levels in Kawasaki disease: a possible marker for Kawasaki disease. Angiology 44: 719–723
5.
Zurück zum Zitat Sakai M, Asayama K, Otabe H, Kohri T, Shirahata A (2001) Low tissue plasminogen activator relative to plasminogen activator inhibitor-1 as a marker of cardiac complication in children with Kawasaki disease. Clin Appl Thrombosis/Hemostasis 7: 214–218 Sakai M, Asayama K, Otabe H, Kohri T, Shirahata A (2001) Low tissue plasminogen activator relative to plasminogen activator inhibitor-1 as a marker of cardiac complication in children with Kawasaki disease. Clin Appl Thrombosis/Hemostasis 7: 214–218
6.
Zurück zum Zitat Savage CO, Cooke SP (1993) The role of the endothelium in systemic vasculitis. J Autoimmun 6: 237–249CrossRefPubMed Savage CO, Cooke SP (1993) The role of the endothelium in systemic vasculitis. J Autoimmun 6: 237–249CrossRefPubMed
Metadaten
Titel
Impact of increased D-dimer concentrations in Kawasaki disease
verfasst von
Toshihiko Imamura
Takao Yoshihara
Kentaro Yokoi
Noriko Nakai
Hiroyuki Ishida
Yasuo Kasubuchi
Publikationsdatum
01.08.2005
Verlag
Springer-Verlag
Erschienen in
European Journal of Pediatrics / Ausgabe 8/2005
Print ISSN: 0340-6199
Elektronische ISSN: 1432-1076
DOI
https://doi.org/10.1007/s00431-005-1699-7

Weitere Artikel der Ausgabe 8/2005

European Journal of Pediatrics 8/2005 Zur Ausgabe

Update Pädiatrie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.